| Autor: |
de Freitas, Robson Borba, Tomazele Rovani, Bruno, Augusti Boligon, Aline, de Brum, Thiele Faccim, Piana, Mariana, da Silva Jesus, Roberta, Fantinel Veloso, Carolina, Kober, Helena, Noal Moresco, Rafael, da Costa Araldi, Isabel Cristina, de Freitas Bauermann, Liliane, Linde Athayde, Margareth |
| Předmět: |
|
| Zdroj: |
Molecules; Jul2013, Vol. 18 Issue 7, p7570-7583, 14p, 1 Color Photograph, 1 Chart, 6 Graphs |
| Abstrakt: |
Nowadays there is an increase in the number of people taking herbals worldwide. Scutia buxifolia is used for the treatment of hypertension, but little is known about its action on liver. Thirty-two Wistar rats were divided into four groups: control and groups treated during 30 days with 100, 200 and 400 mg of lyophilized aqueous extract of S. buxifolia (SBSB)/kg of body weight. This study was planned to explore hepatotoxic effect of SBSB, which was assessed by serum transaminases (ALT and AST). Thiobarbituric acid reactive substances (TBARS) levels were determined in liver, along with thiols content (NPSH), catalase (CAT) activity and, superoxide dismutase (SOD) enzymes. Histopathological studies of liver tissue were performed. Flavonoids and phenolics were quantified in SBSB by high performance liquid chromatography with diode array detection (HPLC/DAD). We did not observe alterations on redox status (TBARS, NPSH, CAT and, SOD) in the control and experimental groups. An increase on AST activity was only observed at 200 mg of SBSB, whereas ALT score was not affected by SBSB. Moreover, no morphological alterations were observed on the hepatocytes, matching the analysed biochemical parameters. This way, we conclude that SBSB was not toxic. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
